腾讯网14 小时
礼来(LLY.US)Mounjaro取代诺和诺德(NVO.US)Wegovy 成为英国减肥药新宠
智通财经APP获悉，网上药店数据显示，英国私人购买减肥药的人数持续增长，其中礼来公司(LLY.US)的Mounjaro正逐渐超越诺和诺德公司(NVO.US)的Wegovy，成为消费者的新宠。这一现象标志着美国制药商礼来在欧洲市场竞争中逐渐逼近其对手诺 ...
What is Mounjaro? The Ozempic-style weight-loss drug being rolled out on the NHS
They’ve been heralded as the magic drugs that treat obesity when diet and exercise have failed. But Ozempic and Wegovy – and ...
Force NHS to hand out weight-loss drugs, Blair think tank urges
The decision to limit Mounjaro injections to 220,000 people is ‘short-sighted and absurd’, says the former prime minister’s ...
Mounjaro on the NHS: What you need to know about ‘King Kong of weight-loss drugs’
What you need to know about ‘King Kong of weight-loss drugs’ - The drug, also known as tirzepatide, will be rolled out on the ...
pharmaphorum8 天
Mounjaro cleared for NHS use, but patients may have to wait
Eli Lilly's weight-loss jab Mounjaro has been cleared for rollout by the NHS in England, with around 3.4 million people ...
What is Mounjaro? The new NHS weight loss jab with a 12-year wait
Warning it is ‘not a magic bullet’, Dr Kath McCullough, NHS England’s national speciality adviser for obesity, said: ‘Weight ...
Weight loss drug Mounjaro will be available via the NHS for some people living with obesity
Weight loss jab tirzepatide – commonly sold under the brand name Mounjaro – is set to become available via the NHS for ...
腾讯网8 天
礼来(LLY.US)畅销减肥药Mounjaro将于数月内在英国推出
智通财经APP获悉，英国国家卫生服务局将在未来几个月内开始推出礼来(LLY.US)的畅销减肥药Mounjaro，不过该药物初期只会提供给一小部分患者。英国国家医疗服务体系(NHS)决定限制那些最需要的人获得这些药物，因为它试图控制可能不断膨胀的减肥药账单。英国药品价格监管机构——英国国家健康与护理卓越研究所(NICE)的最终指导 ...
How new NHS weight loss jab Mounjaro works and eligibility amid 12-year waiting list
As the NHS prepares to roll out Mounjaro for patients struggling with obesity, many eligible patients will be facing a ...
NHS gets 12 years to roll out new weight-loss drug Mounjaro
A new weight-loss jab will be rolled out on the NHS in England - but it could take 12 years for everyone to receive it, the ...
NHS Mounjaro warning as most will not be able to access new weightloss drug
The latest Health Survey for England shows that 64% of adults were overweight or obese in 2022. However, Dr Kath McCullough, ...
Lilly's Mounjaro more popular than Wegovy in UK's private obesity drug market
Britons paying privately for obesity drugs are increasingly choosing Eli Lilly's Mounjaro over Novo Nordisk's Wegovy, online pharmacies say, in a sign the U.S. drugmaker is gaining ground on its ...